Odylia Therapeutics 2021 Year End Campaign to Prevent Vision Loss
Our goal is to raise $95,000 by December 31 to support the RPGRIP1 Gene Therapy Program. An anonymous donor will match donations dollar-for-dollar up to $25,000. Your gift will be doubled!
A world reImagined…
Odylia is a unique nonprofit biotech bringing life-changing treatments to people with rare genetic disorders, regardless of prevalence or commercial interest. We help groups navigate the complexity of bringing treatments from the lab to patients.
reThinking rare disease…
Odylia is recreating how treatments can be brought to patients with rare disease. By building innovative partnerships and unique solutions, we are changing the paradigm of drug development for rare disease.
Learn how we are making a difference
Gene Therapy Pipeline
Brydge Solutions
Our Origin Story
Case Studies
reImagine with us…
With little commercial interest in treatments for rare disease, Odylia relies on contributions from individuals, other nonprofit organizations, patient groups, and corporate donors to bring life-changing treatments to patients. Learn more about how you can make a difference.
